Abstract A35: A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcomaNeerav Shukla, Marc Ladanyi, Julia A. Bridge et al.|Cancer Research|2014Cited by 1